FR2536278A1 - Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies - Google Patents
Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies Download PDFInfo
- Publication number
- FR2536278A1 FR2536278A1 FR8219294A FR8219294A FR2536278A1 FR 2536278 A1 FR2536278 A1 FR 2536278A1 FR 8219294 A FR8219294 A FR 8219294A FR 8219294 A FR8219294 A FR 8219294A FR 2536278 A1 FR2536278 A1 FR 2536278A1
- Authority
- FR
- France
- Prior art keywords
- dna
- therapeutic composition
- wound healing
- composition
- composition useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 5
- 230000029663 wound healing Effects 0.000 title abstract description 3
- 229960000458 allantoin Drugs 0.000 claims abstract description 4
- 102000053602 DNA Human genes 0.000 claims description 14
- 108020004414 DNA Proteins 0.000 claims description 14
- 238000011282 treatment Methods 0.000 claims description 7
- 206010052428 Wound Diseases 0.000 claims description 6
- 208000027418 Wounds and injury Diseases 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 abstract description 6
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 241000656145 Thyrsites atun Species 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 208000026802 afebrile Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229940100656 nasal solution Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8219294A FR2536278A1 (fr) | 1982-11-18 | 1982-11-18 | Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies |
| DE8383402044T DE3365162D1 (en) | 1982-11-18 | 1983-10-21 | Therapeutical composition comprising dna and allantoine especially useful in the cicatrization of wounds |
| EP83402044A EP0109873B1 (fr) | 1982-11-18 | 1983-10-21 | Composition thérapeutique à base d'ADN et d'allantoine utile notamment pour la cicatrisation des plaies |
| US06/549,558 US4560678A (en) | 1982-11-18 | 1983-11-07 | Novel therapeutic composition useful particularly for healing wounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8219294A FR2536278A1 (fr) | 1982-11-18 | 1982-11-18 | Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2536278A1 true FR2536278A1 (fr) | 1984-05-25 |
| FR2536278B1 FR2536278B1 (enExample) | 1985-04-12 |
Family
ID=9279283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8219294A Granted FR2536278A1 (fr) | 1982-11-18 | 1982-11-18 | Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4560678A (enExample) |
| EP (1) | EP0109873B1 (enExample) |
| DE (1) | DE3365162D1 (enExample) |
| FR (1) | FR2536278A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6743782B1 (en) | 1987-10-28 | 2004-06-01 | Wellstat Therapeutics Corporation | Acyl deoxyribonucleoside derivatives and uses thereof |
| US6919320B1 (en) | 1987-10-28 | 2005-07-19 | Wellstat Therapeutics Corporation | Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
| US6020322A (en) | 1993-11-09 | 2000-02-01 | Pro-Neuron, Inc. | Acyl deoxyribonucleoside derivatives and uses thereof |
| US5246708A (en) * | 1987-10-28 | 1993-09-21 | Pro-Neuron, Inc. | Methods for promoting wound healing with deoxyribonucleosides |
| US6348451B1 (en) | 1987-10-28 | 2002-02-19 | Pro-Neuron, Inc. | Acyl deoxyribonucleoside derivatives and uses thereof |
| EP0355131B1 (en) * | 1987-10-28 | 1996-09-04 | Pro-Neuron, Inc. | Acyl deoxyribonucleoside derivatives and uses thereof |
| ZA892928B (en) * | 1988-04-25 | 1991-01-30 | Pro Neuron Inc | Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
| US7169765B1 (en) | 1988-10-27 | 2007-01-30 | Wellstat Therapeutics Corporation | Acyl deoxyribonucleoside derivatives and uses thereof |
| FR2676926B1 (fr) * | 1991-05-30 | 1993-10-01 | Pierre Flecchia | Compositions pharmaceutiques a base de polydesoxyribonucleotides et leur procede de preparation. |
| EP0712936B1 (en) * | 1993-05-24 | 2002-02-06 | Nauchno-Proizvodstvennoe Predpriyatie "Farmek" | Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| US6444651B1 (en) * | 1997-09-03 | 2002-09-03 | Asama Chemical Co., Ltd. | Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents |
| CA2332369A1 (en) * | 1998-05-27 | 1999-12-02 | Euroceltique S.A. | Drug delivery system comprising a tightly compacted solid medicament stock |
| JP2002541822A (ja) | 1999-04-14 | 2002-12-10 | エム ユー エス シー ファンデーション フォー リサーチ ディベロップメント | 組織特異的および病原体特異的毒性物質ならびにリボザイム |
| ES2274372T3 (es) | 1999-05-27 | 2007-05-16 | Euro-Celtique S.A. | Uso de antisepticos en la fabricacion de un preparado farmaceutico para la prevencion o el tratamiento de inflamaciones en el interior del cuerpo humano. |
| US7297344B1 (en) | 1999-05-27 | 2007-11-20 | Euro-Celtique, S.A. | Preparations for the promotion of wound healing in the upper respiratory tract and/or ear |
| US7300667B1 (en) | 1999-05-27 | 2007-11-27 | Euro-Celtique, S.A. | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
| CA2491034A1 (en) * | 2002-06-26 | 2004-01-08 | The Penn State Research Foundation | Methods and materials for treating human papillomavirus infections |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3326892A (en) * | 1965-04-16 | 1967-06-20 | Irwin I Lubowe | Allantoin sodium ribonucleinate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966967A (en) * | 1973-03-21 | 1976-06-29 | The Regents Of The University Of California | Compositions and methods of treating psoriasis with vinyligs of desmethyl retinoic acid |
| US4330527A (en) * | 1979-11-13 | 1982-05-18 | Teruo Arima | Wound treatment agent |
| US4347841A (en) * | 1981-03-11 | 1982-09-07 | Human Oltoanyagtermelo Es Kutato Intezet | Biological wound covering and method for producing same |
-
1982
- 1982-11-18 FR FR8219294A patent/FR2536278A1/fr active Granted
-
1983
- 1983-10-21 EP EP83402044A patent/EP0109873B1/fr not_active Expired
- 1983-10-21 DE DE8383402044T patent/DE3365162D1/de not_active Expired
- 1983-11-07 US US06/549,558 patent/US4560678A/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3326892A (en) * | 1965-04-16 | 1967-06-20 | Irwin I Lubowe | Allantoin sodium ribonucleinate |
Non-Patent Citations (1)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 63, no. 4, 16 août 1965, colonnes 4096h-4097a, COLUMBUS, Ohio (US) * |
Also Published As
| Publication number | Publication date |
|---|---|
| US4560678A (en) | 1985-12-24 |
| EP0109873B1 (fr) | 1986-08-06 |
| EP0109873A1 (fr) | 1984-05-30 |
| DE3365162D1 (en) | 1986-09-11 |
| FR2536278B1 (enExample) | 1985-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0109873B1 (fr) | Composition thérapeutique à base d'ADN et d'allantoine utile notamment pour la cicatrisation des plaies | |
| FR2459661A1 (fr) | Nouvelle composition medicamenteuse a base de plantes, et procede de preparation | |
| EP0107526B1 (fr) | Pâte pour la protection de la peau | |
| FR2810243A1 (fr) | Timbre transdermique pour medicaments anti-inflammatoires non steroidiens | |
| EP1909844A1 (en) | Topical formulations containing sporopollenin | |
| CA2693644C (fr) | Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique | |
| AU719360B2 (en) | Topical compositions containing a beta-cyclodextrin and an amino polysaccharide | |
| WO2015173522A1 (fr) | Composition antimicrobienne comprenant un glucide, de la glucose oxydase et de l'oxyde de zinc | |
| FR2504551A1 (fr) | Compositions aromatiques possedant des proprietes biologiques et medicaments les renfermant | |
| WO2016030609A1 (fr) | Composition antimicrobienne | |
| CH699182B1 (fr) | Mélanges de miel d'abeilles pour le traitement dermatologique des plaies chroniques. | |
| EP0843556A1 (fr) | Compositions pharmaceutiques a base de gels de type glyceryl poly(meth)acrylate | |
| EP0391780B1 (fr) | Composition anti-démangeaisons | |
| FR2634121A1 (fr) | Procede de preparation de microparticules de collagene et produits obtenus | |
| EP2309981A2 (fr) | Composition dermatologique utilisable notamment pour le soin et la prevention des escarres | |
| BE1015498A5 (fr) | Composition et utilisation de l'iode pur dissout dans l'huile essentielle de melaleuca alternifolia et/ou de melaleuca quinquinervia. | |
| RU2828720C1 (ru) | Мазь "Воскопант" | |
| RU2248198C2 (ru) | Препарат противоожоговый | |
| RU2256441C1 (ru) | Мазь для лечения ожогов, гнойных и инфицированных ран различной этиологии и способ лечения ожогов, гнойных и инфицированных ран | |
| EP3999132B1 (fr) | Traitement ecobiologique des effets secondaires de la radiotherapie | |
| EP0226506A2 (fr) | Composition médicamenteuse destinée à être utilisée dans les indications de la rhumatologie et de la traumatologie | |
| RU2553633C1 (ru) | Мазь для лечения гнойных и открытых ран | |
| WO2019080983A1 (fr) | Nouvelle formulation a base de chitosane et son procede de preparation. | |
| RU2112505C1 (ru) | Серная мазь | |
| EP0404661A2 (fr) | Utilisation de lipopolysaccharides extraits de bactéries gram (-) pour la fabrication d'un médicament facilitant la cicatrisation de la peau |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |